Dave has over 30 years of commercial, financial, and general management experience in life sciences and technology. During that time, he has held senior leadership positions in public companies including Biomarin and Genentech, and in emerging growth, venture-backed companies. Most recently, Dave was the Vice President of Global Commercial Operations at BioMarin where he was responsible for a broad array of commercial functions including US managed markets and trade, US hub operations, global price management, global launch sequencing and market prioritization, global revenue planning & business analytics, global customer order management, and commercial systems. Over his tenure in biotechnology, he has supported therapies in rare disease, oncology, immunology, ophthalmology, and other specialty drug areas. Dave has developed pricing strategies for chronic therapies and gene therapies. He has experience with all product life-cycle stages from pipeline to launch, through growth and maturity including generic competition. He has worked with distribution partners including specialty pharmacies and wholesalers in the US, and with full-service distribution partners and 3PLs outside of the US. Dave holds a BS in Business Administration from the University of California, Berkeley, and an MBA from the JL Kellogg School of Management at Northwestern University. He also earned a certificate in Biotechnology for Business from Duke University.